TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Bio-Works Technologies AB
Closing information (x1000 DKK)
| Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Turnover |
29,484
|
27,611
|
15,931 |
| Financial expenses |
2
|
15
|
13 |
| Earnings before taxes |
-36,763
|
-29,867
|
-6,813 |
| EBITDA |
-37,437
|
-30,485
|
-6,642 |
| Total assets |
41,746
|
61,219
|
87,882 |
| Current assets |
40,074
|
59,593
|
86,585 |
| Current liabilities |
12,170
|
15,985
|
8,982 |
| Equity capital |
29,576
|
45,234
|
78,900 |
| - share capital |
2,618
|
2,351
|
2,536 |
| Employees (average) |
39
|
43
|
32 |
Financial ratios
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Solvency |
70.8%
|
73.9%
|
89.8% |
| Turnover per employee |
756
|
642
|
498 |
| Profit as a percentage of turnover |
-124.7%
|
-108.2%
|
-42.8% |
| Return on assets (ROA) |
-88.1%
|
-48.8%
|
-7.7% |
| Current ratio |
329.3%
|
372.8%
|
964.0% |
| Return on equity (ROE) |
-124.3%
|
-66.0%
|
-8.6% |
| Change turnover |
1,730
|
12,970
|
10,671 |
| Change turnover % |
6%
|
89%
|
203% |
| Chg. No. of employees |
-4
|
11
|
1 |
| Chg. No. of employees % |
-9%
|
34%
|
3% |
Total value of public sale
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.